CELL AON
LIVE

Serial Number

97700283

Owner

Cellares Corporation

Attorney

Bobby A. Ghajar

Filing Date

Dec 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CELL AON Trademark

Serial Number: 97700283

CELL AON is a trademark filed by Cellares Corporation on December 1, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Cellares Corporation (38 trademarks)

South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

December 1, 2022

Registration Date

Not Registered

Published for Opposition

October 31, 2023

Goods & Services

Bioprocessing equipment in the nature of scientific systems for bioprocessing of cellular material and performing fluidic transfers comprised of computer hardware, recorded software, bioprocessing instruments in the nature of pumps, elutriators, magnetic separators, and electroporators, and disposables in the nature of cartridges including mixers, impellers, and bioreactors, all of the aforementioned equipment sold as a unit for the manufacturing of therapeutics and biologics-based drug delivery vehicles; Downloadable computer software for accessing a database featuring information in the medical field, specifically, cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; Scientific and laboratory apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies in the nature of laboratory centrifuges, cell sorting apparatus, bioreactors for laboratory use, and parts and fittings for all of the aforesaid goods; Fully integrated laboratory apparatus and computer systems, namely, computer systems comprised of a graphical user interface, processor, and server for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Downloadable software for the manufacturing of autologous and allogeneic cell therapies; Downloadable software for automating the operations of biotechnological instruments used with manufacturing equipment for biological cell therapies; Downloadable software for the execution, monitoring, analysis of cell therapy manufacturing workflows as well as process development workflows; Downloadable software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material, namely, allogeneic and autologous cells; Downloadable software for generating electronic batch records for cell therapies

Medical equipment in the nature of an instrument docking station and a cartridge for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system, namely, a fluidic transfer system, chambers for cell processing, and corresponding instrumentation including a fluidic transfer system, chambers for cell processing, and corresponding instrumentation for use in the creation of biological cell therapies for medical purposes; Medical bags and containers in the nature of disposable single-use containers adapted for and sold for solutions used for the manufacturing of autologous and allogeneic biological cell therapies for medical use, namely, bags, pouches, cartridges, namely, for transferring and/or processing of allogeneic or autologous cellular material; rigid and semi-rigid containers for concentrates and solutions in solid or liquid form, all of the aforesaid being for medical use; the foregoing excludes containers that are used to transport or ship temperature-sensitive goods, medicines, pharmaceuticals, and biologics in an insulated- or temperature-controlled manner

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 2, 2025 EX4G
SOU EXTENSION 4 FILED
Dec 2, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 27, 2025 EX3G
SOU EXTENSION 3 FILED
May 27, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 25, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 25, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 22, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 31, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 30, 2024 EX1G
SOU EXTENSION 1 FILED
May 30, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 30, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Apr 11, 2023 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 11, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2022 NWOS
NEW APPLICATION ENTERED
Dec 5, 2022 NWAP